Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Entrada Therapeutics (NASDAQ: TRDA)
Follow
NASDAQ:TRDA
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
TRDA
Entrada Therapeutics
WENTWORTH KORY JAMES
/
officer: Chief Financial Officer
11/21/2025
Sell
$9.98
8,910
$89K
110,026
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/20/2025
Buy
$9.07
13,082
$119K
4.69M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/20/2025
Buy
$9.07
13,386
$121K
4.68M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/20/2025
Buy
$9.07
1,186
$11K
381,338
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/20/2025
Buy
$9.07
1,213
$11K
380,152
NASDAQ
TRDA
Entrada Therapeutics
PARMAR KUSH
/
director, 10 percent owner:
11/14/2025
Sell
$8.80
200,000
$1.760M
2.96M
NASDAQ
TRDA
Entrada Therapeutics
5AM Ventures V, L.P.
/
10 percent owner
11/14/2025
Sell
$8.80
200,000
$1.760M
2.96M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/12/2025
Buy
$7.95
11,494
$91K
4.66M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/12/2025
Buy
$7.73
80,881
$625K
4.65M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/11/2025
Buy
$7.54
30,879
$233K
4.57M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/11/2025
Buy
$7.39
11,701
$86K
4.54M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/10/2025
Buy
$7.22
2,947
$21K
4.53M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/10/2025
Buy
$7.21
25,364
$183K
4.53M
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/12/2025
Buy
$7.95
1,040
$8K
378,939
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/12/2025
Buy
$7.73
7,321
$57K
377,899
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/11/2025
Buy
$7.54
2,795
$21K
370,578
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/11/2025
Buy
$7.39
1,059
$8K
367,783
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/10/2025
Buy
$7.22
267
$2K
366,724
NASDAQ
TRDA
Entrada Therapeutics
BAKER BROS. ADVISORS LP
/
10 percent owner
11/10/2025
Buy
$7.21
2,296
$17K
366,457
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.